http://www.unboundmedicine.com/medline/ebm/research/ziprasidoneUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/18955945/full_citation/Long_term_improvement_in_efficacy_and_safety_after_switching_to_ziprasidone_in_stable_outpatients_with_schizophrenia_Simpson GM, O'Gorman CJ, Loebel A, et al. 
Long-term improvement in efficacy and safety after switching to ziprasidone in stable outpatients with schizophrenia. [Journal Article]
CNS Spectr 2008 Oct; 13(10):898-905.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/18954497/full_citation/One_year_clinical_and_economic_consequences_of_oral_atypical_antipsychotics_in_the_treatment_of_schizophrenia_Edwards NC, Pesa J, Meletiche DM, et al. 
One-year clinical and economic consequences of oral atypical antipsychotics in the treatment of schizophrenia. [JOURNAL ARTICLE]
Curr Med Res Opin 2008 Oct 23.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/18950992/full_citation/The_use_of_ziprasidone_in_clinical_practice:_Analysis_of_pharmacokinetic_and_pharmacodynamic_aspects_from_data_of_a_drug_monitoring_survey_Vogel F, Gansmüller R, Leiblein T, et al. 
The use of ziprasidone in clinical practice: Analysis of pharmacokinetic and pharmacodynamic aspects from data of a drug monitoring survey. [JOURNAL ARTICLE]
Eur Psychiatry 2008 Oct 22.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/18950388/full_citation/Aripiprazole_resolves_amisulpride_and_ziprasidone_induced_hyperprolactinemia_Saitis M, Papazisis G, Katsigiannopoulos K, et al. 
Aripiprazole resolves amisulpride and ziprasidone-induced hyperprolactinemia. [Letter]
Psychiatry Clin Neurosci 2008 Oct; 62(5):624.
Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/18928413/full_citation/Tolerability_of_oral_ziprasidone_in_children_and_adolescents_with_bipolar_mania_schizophrenia_or_schizoaffective_disorder_DelBello MP, Versavel M, Ice K, et al. 
Tolerability of oral ziprasidone in children and adolescents with bipolar mania, schizophrenia, or schizoaffective disorder. [Journal Article, Research Support, Non-U.S. Gov't]
J Child Adolesc Psychopharmacol 2008 Oct; 18(5):491-9.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/18924059/full_citation/[Therapeutic_Options_for_Weight_Management_in_Schizophrenic_Patients_Treated_with_Atypical_Antipsychotics_]Cordes J, Sinha-Röder A, Kahl KG, et al. 
[Therapeutic Options for Weight Management in Schizophrenic Patients Treated with Atypical Antipsychotics.] [JOURNAL ARTICLE]
Fortschr Neurol Psychiatr 2008 Oct 15.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/18850047/full_citation/Gateways_to_clinical_trials_Tomillero A, Moral MA 
Gateways to clinical trials. [JOURNAL ARTICLE]
Methods Find Exp Clin Pharmacol 2008 July/August; 30(6):459-495.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/18840034/full_citation/Sleep_Disturbances_in_Patients_with_Schizophrenia_:_Impact_and_Effect_of_Antipsychotics_Cohrs S 
Sleep Disturbances in Patients with Schizophrenia : Impact and Effect of Antipsychotics. [JOURNAL ARTICLE]
CNS Drugs 2008; 22(11):939-962.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/18832504/full_citation/Psychotropic_medications_for_patients_with_bipolar_disorder_in_the_United_States:_polytherapy_and_adherence_Baldessarini R, Henk H, Sklar A, et al. 
Psychotropic medications for patients with bipolar disorder in the United States: polytherapy and adherence. [Journal Article, Research Support, Non-U.S. Gov't]
Psychiatr Serv 2008 Oct; 59(10):1175-83.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/18831971/full_citation/Characterization_of_aripiprazole_partial_agonist_activity_at_human_dopamine_D_3__receptors_Tadori Y, Forbes RA, McQuade RD, et al. 
Characterization of aripiprazole partial agonist activity at human dopamine D(3) receptors. [JOURNAL ARTICLE]
Eur J Pharmacol 2008 Sep 20.
Abstract | Full Citation